Treatment of Pancreatic Ascites with Endoscopic Pancreatic Duct Stenting and Octreotide Injection.
- Author:
In Ho KIM
1
;
Seung Il PYO
;
Yun Jung LEE
;
Sa Rah PARK
;
Hyun Young KIM
;
Sang Taek HAN
;
Hyun Ju PARK
;
Yeon Ho JOO
;
Dong Wan SEO
;
Sung Koo LEE
;
Myung Hwan KIM
;
Young Il MIN
Author Information
1. Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
- Publication Type:Case Report
- Keywords:
Pancreatic ascites;
Octreotide;
Endoscopic pancreatic duct stenting
- MeSH:
Abdominal Pain;
Ascites*;
Humans;
Octreotide*;
Pancreatic Ducts*;
Pancreatitis, Chronic;
Paracentesis;
Parenteral Nutrition, Total;
Rupture;
Stents*;
Weight Loss
- From:Korean Journal of Gastrointestinal Endoscopy
2000;21(2):662-665
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Pancreatic ascites is an exudative which is an amylase-rich accumulation of intraperitoneal fluid and occurs in association with rupture of a pseudocyst or disruption of the pancreatic duct. Characteristically the patient presents with increasing abdominal girth, weight loss, and varying degrees of abdominal pain. Conservative medical management, including withholding of oral feeding, total parenteral nutrition, and large volume paracentesis has led to successful resolution of pancreatic ascites in less than 50% of cases. Recently octreotide injection and endoscopic transpapillary pancreatic duct stenting have made a major impact on the conservative treatment of pancreatic ascites. We describe the case of a patient with chronic pancreatitis and pancreatic ascites who was treated by endoscopic pancreatic duct stenting and octreotide injection.
